1887

Abstract

The purpose of this study was to compare the frequency of recovery of aerobic and anaerobic organisms with interfering capability against group A -haemolytic streptococci (GABHS) and -lactamase-producing bacteria (BLPB) from the tonsils of GABHS carriers and non-carriers. The presence of aerobic and anaerobic bacteria capable of such interference was evaluated in cultures obtained from the tonsils of 20 healthy children who were non-GABHS carriers and 20 who were GABHS carriers, and also from 20 children who were asymptomatic after completing a course of penicillin for acute GABHS pharyngo-tonsillitis (PT) and were non-GABHS carriers and 20 who were GABHS carriers. In healthy children, 32 interfering isolates were recovered from 16 non-GABHS carriers (1.6 per child) and 13 were isolated from 7 GABHS carriers (0.65 per child) (<0.001). In children who had suffered acute GABHS PT, 26 interfering organisms were recovered from 15 non-GABHS carriers (1.3 per child) and 8 were isolated from 5 GABHS carriers (0.4 per child) (<0.005). In healthy children, 13 BLPB were recovered from 5 non-GABHS carriers and 13 were isolated from 6 GABHS carriers. In children who had suffered acute GABHS PT, 14 BLPB were recovered from 5 (25 %) non-GABHS carriers and 32 were isolated from 17 (85 %) GABHS carriers (<0.05). It was demonstrated in this study that there was a higher rate of recovery of aerobic and anaerobic organisms capable of interfering with GABHS in non-GABHS carriers than in GABHS carriers. This was observed in all GABHS non-carriers and included healthy children as well as those recently treated for symptomatic GABHS PT with penicillin that failed to eradicate GABHS. A higher rate of recovery of BLPB was observed only in GABHS carriers who were treated with penicillin for GABHS PT.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46796-0
2006-12-01
2019-11-13
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/12/1741.html?itemId=/content/journal/jmm/10.1099/jmm.0.46796-0&mimeType=html&fmt=ahah

References

  1. Bisno, A. L. ( 1991; ). Group A streptococcal infections and acute rheumatic fever. N Engl J Med 325, 783–793.[CrossRef]
    [Google Scholar]
  2. Brook, I. ( 1984; ). The role of β-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 6, 601–607.[CrossRef]
    [Google Scholar]
  3. Brook, I. ( 2001; ). The role of β-lactamase producing bacteria and bacterial interference in streptococcal tonsillitis. Int J Antimicrob Agents 17, 439–442.[CrossRef]
    [Google Scholar]
  4. Brook, I. ( 2005; ). The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg 133, 139–146.[CrossRef]
    [Google Scholar]
  5. Brook, I. & Foote, P. A. ( 2005; ). Efficacy of penicillin versus cefdinir in eradication of group A streptococci and tonsillar flora. Antimicrob Agents Chemother 49, 4787–4788.[CrossRef]
    [Google Scholar]
  6. Brook, I. & Gober, A. E. ( 1995; ). Role of bacterial interference and β-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis. Arch Otolaryngol Head Neck Surg 121, 1405–1409.[CrossRef]
    [Google Scholar]
  7. Brook, I. & Gober, A. E. ( 1999; ). Interference by aerobic and anaerobic bacteria in children with recurrent group A β-hemolytic streptococcal tonsillitis. Arch Otolaryngol Head Neck Surg 125, 552–554.[CrossRef]
    [Google Scholar]
  8. Casey, J. R. & Pichichero, M. E. ( 2004; ). Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics 113, 866–882.[CrossRef]
    [Google Scholar]
  9. Cockerill, F. R., III, MacDonald, K. L., Thompson, R. L. and 11 other authors ( 1997; ). An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA 277, 38–43.[CrossRef]
    [Google Scholar]
  10. Crowe, C. C., Sanders, E. & Longley, S. ( 1973; ). Bacterial interference, II: the role of the normal throat flora in prevention of colonization by group A streptococcus. J Infect Dis 128, 527–532.[CrossRef]
    [Google Scholar]
  11. Finegold, S. M. & Sutter, V. ( 1976; ). Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother 10, 736–752.[CrossRef]
    [Google Scholar]
  12. Grahn, E., Holm, S. E., Ekedahl, C. & Roos, K. ( 1983; ). Interference of α-hemolytic streptococci isolated from tonsillar surface on β-hemolytic streptococci (Streptococcus pyogenes) – a methodological study. Zentralbl Bakteriol Mikrobiol Hyg A 254, 459–468.
    [Google Scholar]
  13. Murray, P. R., Baron, E. J., Jorgensen, J. H., Pfaller, M. A. & Yolken, R. H. ( 2003; ). Manual of Clinical Microbiology, 8th edn. Washington DC: American Society for Microbiology.
  14. O'Brien, K. L., Beall, B., Barrett, N. L. and 8 other authors ( 2002; ). Epidemiology of invasive group A streptococcus disease in the United States, 1995–1999. Clin Infect Dis 35, 268–276.[CrossRef]
    [Google Scholar]
  15. Pichichero, M. E., Marsocci, S. M., Lynd Murphy, A. M. & Hoeger, W. ( 1999; ). Incidence of streptococcal carriers in private pediatric practice. Arch Pediatr Adolesc Med 153, 624–628.[CrossRef]
    [Google Scholar]
  16. Roos, K., Holm, E., Grahn-Hakansson, E. & Lagergren, L. ( 1996; ). Recolonization with selected α-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis – a randomized placebo-controlled multicenter study. Scand J Infect Dis 28, 459–462.[CrossRef]
    [Google Scholar]
  17. Summanen, P., Baron, E. J., Citron, D. M., Strong, C. A., Wexler, H. M. & Finegold, S. M. ( 1995; ). Wadsworth Anaerobic Bacteriology Manual, 5th edn. Belmont, CA: Star Publishing.
  18. Tanz, R. R., Shulman, S. T., Barthel, M. J., Willert, C. & Yogev, R. ( 1985; ). Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr 106, 876–880.[CrossRef]
    [Google Scholar]
  19. Tanz, R. R., Poncher, J. R., Corydon, K. E., Kabat, K., Yogev, R. & Shulman, S. T. ( 1991; ). Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr 119, 123–128.[CrossRef]
    [Google Scholar]
  20. Walls, T., Power, D. & Tagg, J. ( 2003; ). Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media? J Med Microbiol 52, 829–833.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46796-0
Loading
/content/journal/jmm/10.1099/jmm.0.46796-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error